SEA BASS & SEA BREAM
How acoustic technologies are aiding fish health and welfare
Monitoring fish using sound is on the rise in aquaculture, meeting a need to accurately assess the health and welfare of farmed-fish populations in changing environments.
Data and feed helping tackle some of Europe’s prevalent fish-health threats
A Europe-wide project is helping establish new approaches to tackle economically important parasites and pathogens, both in the Mediterranean and Norway.
Managing health risks in Mediterranean aquaculture’s least-controllable environment
The consolidation of Mediterranean aquaculture is standardizing production practices in the region and leading to better biosecurity management, but growing out fish in the unforgiving environment at sea poses the sort of challenge that demands realistic, practical solutions.
New approach could improve understanding of farmed seabream welfare
Analyzing proteins from the skin mucus of gilthead seabream (Sparus aurata) could offer a promising, welfare-friendly route to monitor stress levels of the fish during production cycles.
Helping Mediterranean fish farmers quickly identify disease issues
An interview with Emre Berke, DVM, PhD, field technical support associate for PHARMAQ.
Revealing farmed sea bream’s diverse microbiome could aid health improvements
The microbiome of gilthead seabream farmed in the Mediterranean appears to be very distinct from that of their surrounding environment — offering new insight which may help in managing health issues associated with the species.
Diversity of sea bass pathogen strains highlights challenge in Mediterranean aquaculture
A new study analyzing three strains of the bacterium Vibrio harveyi found among farmed sea bass in the Mediterranean has underlined the diversity of the pathogen, which poses a severe threat to the region’s aquaculture.
Sea bass immunity to parasitic disease could lead to new treatments
No effective licensed therapies exist against amyloodiniosis, a disease of fish species caused by Amyloodinium ocellatum (AO) ectoparasites. However, new research has shown that European sea bass (ESB) can develop specific immunity to the disease, which could in turn lead to the development of vaccines.
Advanced diagnostic approaches for fish disease are welcome, but sometimes simpler is better
With technologies for molecular diagnosis of fish disease increasingly available, sometimes simpler approaches that have great diagnostic power are being ignored.
Safety and welfare concerns drive shift to licensed anesthetic in Mediterranean aquaculture
Improving standards on Mediterranean fish farms is driving interest in Tricaine PHARMAQ — the only authorized fish anesthetic product.